OpenBilldrug price receipt

NADAC week of 2026-10-14

SEVELAMER HCL 800 MG TABLET

For 30 tablets

Pharmacies pay

$20.86 filed

30 × $0.69517 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$104.69 filed

30 × $3.48977 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

5.0× estimated

Medicare paid 5.0× what pharmacies pay.

Part D averages every strength and form sold under “Sevelamer HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$28.99 estimated

$20.86 + $3.13 (15%) + $5.00 fee per fill = $28.99

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

SEVELAMER HCL 800 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as sevelamer hydrochloride.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as “parenteral” and “oral”.

FDA lists 7 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Macleods Pharmaceuticals Limited and Aurobindo Pharma Limited.

FDA’s Established Pharmacologic Class for it is Phosphate Binder.

The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes); the FDA directory lists 7 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $20.86 for 30 tablets (30 × $0.69517 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 7 labelers

LabelerNDCsPharmacies pay per unit
American Health Packaging1$0.69517 per EA filed
Aurobindo Pharma Limited1$0.69517 per EA filed
Glenmark Pharmaceuticals Inc., USA1$0.69517 per EA filed
Lupin Pharmaceuticals, Inc.1$0.69517 per EA filed
Macleods Pharmaceuticals Limited1$0.69517 per EA filed
Major Pharmaceuticals1$0.69517 per EA filed
Zydus Pharmaceuticals USA Inc.1$0.69517 per EA filed
Not listed as a package in the FDA directory1$0.69517 per EA filed
All 8 NDCs, with labeler and price
  • 00904-7209-06 · Major Pharmaceuticals · $0.69517 per EA · eff. 2026-09-23 filed
  • 33342-0242-57 · Macleods Pharmaceuticals Limited · $0.69517 per EA · eff. 2026-09-23 filed
  • 59651-0088-18 · Aurobindo Pharma Limited · $0.69517 per EA · eff. 2026-09-23 filed
  • 60687-0449-01 · American Health Packaging · $0.69517 per EA · eff. 2026-09-23 filed
  • 60687-0449-11 · not listed as a package in the FDA directory · $0.69517 per EA · eff. 2026-09-23 filed
  • 68462-0447-18 · Glenmark Pharmaceuticals Inc., USA · $0.69517 per EA · eff. 2026-09-23 filed
  • 70710-2058-08 · Zydus Pharmaceuticals USA Inc. · $0.69517 per EA · eff. 2026-09-23 filed
  • 70748-0173-26 · Lupin Pharmaceuticals, Inc. · $0.69517 per EA · eff. 2026-09-23 filed

Compared with its class

The middle of its 8 NDCs’ NADAC prices is $0.69517 per EA filed.

Of the 34 other products in FDA’s Phosphate Binder class priced per EA, 15 have a higher middle NADAC price and 19 a lower one. The one in the middle is SEVELAMER CARBONATE 800 MG TAB, at $0.214 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $104.69 for 30 tablets, at an average of $3.48977 per EA in 2024 (2024-01-01 to 2024-12-31) for “Sevelamer HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 36,810 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for SEVELAMER HCL 800 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Sevelamer HCl / Sevelamer HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Why does this page start at 30 tablets?
NADAC prices this product per EA, and its NADAC name (“SEVELAMER HCL 800 MG TABLET”) says “TABLET”. The FDA NDC Directory lists 7 of its 8 NDCs (it does not list the other one), 5 of them as oral tablets (dosage forms “TABLET”, “TABLET, FILM COATED”, route “ORAL”), so one EA is one tablet. It lists the other 2 differently: NDC 00904-7209-06 as dosage form “TABLET, FILM COATED” with route “PARENTERAL”; NDC 68462-0447-18 as dosage form “TABLET, FILM COATED” with route “PARENTERAL”. Those match neither the NADAC name nor the product’s other NDCs and look like errors in the listing, so OpenBill goes by the majority. The card starts at 30 tablets, a common one-month supply of a once-a-day medicine; change it to match your prescription.